NEUROONE MEDICAL TECHNOLOGIES CORPORATION

Andere Sprachen NeuroOne Medical Technologies Corporation

Aktien

A3CMM6

US64130M2098

NMTC

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 25.04.2024			% 5 Tage	% 1. Jan.
1.11 ^USD	-4.31%		-2.63%	-29.75%

26.03.	NeuroOne Medical Technologies Corporation beginnt mit der begrenzten Markteinführung des OneRF Ablationssystems	CI
13.02.	Transcript : NeuroOne Medical Technologies Corporation, Q1 2024 Earnings Call, Feb 13, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology	10.04.
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes	09.04.
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.	04.04.
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System	26.03.
NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System	26.03.
NeuroOne to Participate in the 36th Annual Roth Conference	11.03.
NeuroOne® to Participate in the 36th Annual Roth Conference	08.03.
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	23.02.
NeuroOne Medical Technologies Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	13.02.
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	13.02.
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13	08.02.
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Full Year Ended September 30, 2023	14.12.
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update	14.12.
NeuroOne Gets FDA Clearance to Market OneRF Ablation System; Shares Fall	11.12.
NeuroOne Medical Technologies Corporation Receives FDA 510(K) Clearance to Market its OneRF(TM) Ablation System	11.12.
NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System	11.12.
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14	07.12.
Thinking about buying stock in Adial Pharmaceuticals, Ares Capital Corp, SilverSun Technologies, Neuroone Medical Technologies, or enGene Holdings?	05.12.
NeuroOne Medical Technologies Gets Notice of Allowance for Drug Delivery Patent	16.11.
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe	16.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen NeuroOne Medical Technologies Corporation

Aktien

A3CMM6

US64130M2098

NMTC

Andere Sprachen

Filter